Mejia, Miecel C.

HRN: 23-78-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/29/2023
10/06/2023
IV INFUSION
4.5
Q8hr
Sepsis
Checking Final Appropriateness 

Indication:  Empirical Escalation    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: